Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

NCT06265077 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Filgrastim Adverse Reaction

Interventions

DRUG: Placebo
DRUG: famotidine and loratadine

Sponsor

Noha Mansour